Kotak Small Cap Fund Regular-Growth
The fund is rated 0 stars. The balance between returns and downside risk provided limited support. Investment selection within each asset type and investment selection within each industry were the main limitations and did not provide enough support for a higher rating. Above-average fund size of Rs 19,678.75 crore was a minor drawback.
This fund has a bad track record with Asset Selection/Timing, a bad track record with Stock Selection/Timing. It is important to note, however, that this fund has a 19678.753 AUM and a 1.725 expense ratio. Considering all these factors, we have rated this fund as 0.0 star.
અમારો સ્કોર લાંબા ગાળાની કામગીરી, જોખમ અને સાતત્યને વજન આપે છે — ફક્ત ભૂતકાળના વળતરને નહીં.
રિટર્ન
9 Oct 2026 મુજબ
જોખમ ગુણોત્તર
30 Sep 2026 મુજબ
પોર્ટફોલિયો
31 Aug 2026 મુજબ
માર્કેટ-કેપ વિભાજન
સેક્ટર ફાળવણી
હોલ્ડિંગ્સ (80)
| હોલ્ડિંગ | ફંડનો % | મૂલ્ય | શેર |
|---|---|---|---|
| Aster DM Quality Care Ltd. | 4.29% | ₹844.29 Cr | 1,11,67,820 |
| Vijaya Diagnostic Centre Ltd. | 4.21% | ₹828.24 Cr | 54,54,656 |
| Sansera Engineering Ltd. | 4.15% | ₹816.78 Cr | 20,32,796 |
| Krishna Institute of Medical Sciences Ltd | 3.25% | ₹638.71 Cr | 84,54,118 |
| Kalpataru Projects International Ltd. | 2.54% | ₹500.42 Cr | 35,72,133 |
| Minda Corporation Ltd. | 2.39% | ₹470.8 Cr | 66,07,215 |
| Century Plyboards (India) Ltd. | 2.25% | ₹441.99 Cr | 58,36,731 |
| Five-Star Business Finance Ltd. | 2.12% | ₹416.28 Cr | 77,80,174 |
| Shriram Finance Ltd | 2.03% | ₹399.95 Cr | 36,03,518 |
| Ajanta Pharma Ltd. | 1.99% | ₹391.21 Cr | 10,86,134 |
ફંડ વિગતો
Long term capital growth. Investment in equity & equity related securities predominantly in small cap Stocks.
The scheme seeks to generate capital appreciation from a diversified portfolio of equity and equity related securities by investing predominantly in small cap companies.
Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days